E-cadherin and associated molecules in the invasion and progression of prostate cancer

被引:0
|
作者
Davies, G
Jiang, WG
Mason, MD
机构
[1] Univ Coll N Wales, Dept Surg, Metastasis Res Grp, Cardiff CF4 4XN, S Glam, Wales
[2] Cardiff Univ, Dept Med, Sect Clin Oncol, Velindre Hosp, Cardiff CF4 7XL, S Glam, Wales
关键词
prostate cancer; E-cadherin; catenins; invasion; metastasis; adenomatous polyposis coli;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostatic carcinoma is the most common type of male cancer found in the Western world and its distant metastasis becomes a life threatening event in tumour bearing patients. However, the biology of prostate cancer and metastasis is poorly understood. We review the progress made in the last decade on the molecular and cellular biology of cell-cell adhesion molecules in the invasion and progression of prostate cancer, with emphasis being placed on E-cadherin and its associated molecules.
引用
收藏
页码:1567 / 1576
页数:10
相关论文
共 50 条
  • [21] Dominant role of E-cadherin in the progression of bladder cancer
    Imao, T
    Koshida, K
    Endo, Y
    Uchibayashi, T
    Sasaki, T
    Namiki, M
    JOURNAL OF UROLOGY, 1999, 161 (02): : 692 - 698
  • [22] E-cadherin and α-, β- and γ-catenin expression in prostate cancers:: correlation with tumour invasion
    Morita, N
    Uemura, H
    Tsumatani, K
    Cho, M
    Hirao, Y
    Okajima, E
    Konishi, N
    Hiasa, Y
    BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) : 1879 - 1883
  • [23] E-cadherin and α-, β- and γ-catenin expression in prostate cancers: correlation with tumour invasion
    N Morita
    H Uemura
    K Tsumatani
    M Cho
    Y Hirao
    E Okajima
    N Konishi
    Y Hiasa
    British Journal of Cancer, 1999, 79 : 1879 - 1883
  • [24] Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin
    Zhou, Qiong
    Yan, Bing
    Hu, Xiaowen
    Li, Xue-Bing
    Zhang, Jie
    Fang, Jing
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (06) : 1684 - 1691
  • [25] Expression of E-cadherin in primary and metastatic prostate cancer
    Cheng, L
    Nagabhushan, M
    Pretlow, TP
    Amini, SB
    Pretlow, TG
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (05): : 1375 - 1380
  • [26] E-cadherin polymorphism - 160 C/A and prostate cancer
    Hajdinjak, T
    Toplak, N
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) : 480 - 481
  • [27] Cleavage of E-cadherin and the role of an 80kDA fragment in the metastatic progression of prostate cancer
    Kuefer, R
    Day, K
    Rios-Doria, J
    Hofer, M
    Chinnaiyan, A
    Rubin, MA
    Day, M
    JOURNAL OF UROLOGY, 2004, 171 (04): : 108 - 108
  • [28] Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer
    Tsukino, H
    Kuroda, Y
    Imai, H
    Nakao, H
    Qiu, D
    Komiya, Y
    Inatomi, H
    Hamasaki, T
    Kohshi, K
    Osada, Y
    Katoh, T
    UROLOGIA INTERNATIONALIS, 2004, 72 (03) : 203 - 207
  • [29] E-cadherin/catenin/cytoskeleton complex: A regulator of cancer invasion
    Mareel, M
    Boterberg, T
    Noe, V
    VanHoorde, L
    Vermeulen, S
    Bruyneel, E
    Bracke, M
    JOURNAL OF CELLULAR PHYSIOLOGY, 1997, 173 (02) : 271 - 274
  • [30] Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer
    Miyamoto, S
    Baba, H
    Kuroda, S
    Kaibuchi, K
    Fukuda, T
    Maehara, Y
    Saito, T
    BRITISH JOURNAL OF CANCER, 2000, 83 (09) : 1168 - 1175